Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed that it enclosed the Press Release titled ‘SPARC to provide update on Clinical Programs and R&D Pipeline’.
The above information is a part of company’s filings submitted to BSE.